RNAi has great therapeutic prospects, and siRNA-based drugs are being developed for several pathologies, from viral infections [26] to cancers [27] Therefore, in this study, TGF-β1 siRNA was applied to down-regulate the expression of TGF-β1. Here, TGFB1 is linked to viral infectious disease.